Endoprosthetic reconstruction for malignant upper extremity tumors
- PMID: 10101327
- DOI: 10.1097/00003086-199903000-00025
Endoprosthetic reconstruction for malignant upper extremity tumors
Abstract
Between December 1980 and December 1992, 59 patients underwent 60 reconstructions with endoprostheses after resection of malignant tumors in the upper extremity. There were 32 male patients and 27 female patients, with a mean age of 33 years (range, 3-83 years). The type of reconstruction was based on the location of the primary tumor site. The histologic diagnoses included osteosarcoma, chondrosarcoma, Ewing's sarcoma, malignant fibrous histiocytoma, soft tissue sarcoma, and fibrosarcoma of bone. Most of the patients had Stage IIB disease (N = 38), as established by the Musculoskeletal Tumor Society classification. An additional six patients had metastatic tumors to the upper extremity. Twenty-seven of 59 patients died of disease progression. Two patients died of other causes (chronic leukemia, human immunodeficiency virus infection). The 30 survivors had a mean followup of 90 months (range, 60-170 months). The Musculoskeletal Tumor Society functional analysis for the patients with a minimum 2-year followup (N = 41) averaged 74%. Sixteen of the 59 (27%) patients had local complications. Problems related to mechanical failure and infection were managed successfully with second operation. Amputation was rare, occurring in three of 60 (5%) patients and was related only to local recurrence. Endoprosthetic reconstructions of the upper extremity after tumor resections have proven to be successful.
Similar articles
-
Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.Clin Orthop Relat Res. 2017 Jun;475(6):1702-1711. doi: 10.1007/s11999-017-5258-0. Epub 2017 Feb 13. Clin Orthop Relat Res. 2017. PMID: 28194713 Free PMC article.
-
Endoprosthetic reconstruction for malignant bone and soft-tissue tumors.J Med Assoc Thai. 2007 Apr;90(4):706-17. J Med Assoc Thai. 2007. PMID: 17487125
-
Does total humeral endoprosthetic replacement provide reliable reconstruction with preservation of a useful extremity?Clin Orthop Relat Res. 2015 Mar;473(3):917-25. doi: 10.1007/s11999-014-3635-5. Clin Orthop Relat Res. 2015. PMID: 24801261 Free PMC article.
-
Expandable endoprosthetic reconstruction of the skeletally immature after malignant bone tumor resection.Clin Orthop Relat Res. 1993 Dec;(297):188-202. Clin Orthop Relat Res. 1993. PMID: 8242930
-
The management of malignant bone tumors in children and adolescents.Clin Orthop Relat Res. 1991 Mar;(264):156-68. Clin Orthop Relat Res. 1991. PMID: 1997230 Review.
Cited by
-
Glenoid bone loss in primary and revision shoulder arthroplasty.Shoulder Elbow. 2016 Oct;8(4):229-40. doi: 10.1177/1758573216648601. Epub 2016 May 6. Shoulder Elbow. 2016. PMID: 27660655 Free PMC article.
-
Upper Limb-Salvage Surgery in Pediatric Patients with Malignant Bone Tumors Using Microsurgical Free Flaps: Long-Term Follow-Up.Biomedicines. 2025 Jul 4;13(7):1638. doi: 10.3390/biomedicines13071638. Biomedicines. 2025. PMID: 40722710 Free PMC article.
-
Benefits of a metallic lateralized baseplate prolonged by a long metallic post in reverse shoulder arthroplasty to address glenoid bone loss.Int Orthop. 2019 Sep;43(9):2131-2139. doi: 10.1007/s00264-018-4249-4. Epub 2018 Nov 30. Int Orthop. 2019. PMID: 30506090
-
Use of Ligament Advanced Reinforcement System tube in stabilization of proximal humeral endoprostheses.World J Orthop. 2016 Apr 18;7(4):265-71. doi: 10.5312/wjo.v7.i4.265. eCollection 2016 Apr 18. World J Orthop. 2016. PMID: 27114934 Free PMC article.
-
Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.Clin Orthop Relat Res. 2017 Jun;475(6):1702-1711. doi: 10.1007/s11999-017-5258-0. Epub 2017 Feb 13. Clin Orthop Relat Res. 2017. PMID: 28194713 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical